Early serum uric acid decline and 30-day survival after out-of-hospital cardiac arrest - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Early Changes in Serum Uric Acid and 30-Day Outcomes Following Out-of-Hospital Cardiac Arrest

  • By

  • Tomoyoshi Tamura

  • Ryo Yamamoto

  • Koichiro Homma

  • Nobuya Kitamura

  • Tomohisa Nomura

  • Takashi Tagami

  • Yasuo Yasunaga

  • Shotaro Aso

  • Munekazu Takeda

  • Junichi Sasaki

  • November 20, 2026

Share

Clinical Scorecard: Early Changes in Serum Uric Acid and 30-Day Outcomes Following Out-of-Hospital Cardiac Arrest

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Early Changes in Serum Uric Acid and 30-Day Outcomes Following Out-of-Hospital Cardiac Arrest
Key MechanismsSerum uric acid reflects purine metabolism and the balance of production, renal excretion, and intestinal elimination; the authors note that its change does not directly quantify renal uric acid clearance.
Target PopulationPopulation described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • The prospective multicenter observational study included 375 patients with paired serum uric acid measurements.
  • Admission serum uric acid did not differ significantly between 30-day survivors and non-survivors.
  • A greater 24-hour uric acid decline was associated with 30-day survival (adjusted OR 1.10 per 10-percentage-point increase; 95% CI 1.00–1.20; p=0.048); an analysis accounting for temperature control and pre-arrest renal comorbidity also found an association (adjusted OR 1.09; 95% CI 1.01–1.19; p=0.04).
  • Uric acid decline was associated with 30-day good neurological outcome, defined as CPC 1 or 2 (adjusted OR 1.19 per 10-percentage-point increase; 95% CI 1.05–1.35; p=0.006).
  • The authors state that the association was not shown to be independent of renal dysfunction; serial renal-function and urine-output data were unavailable. Requiring a 24-hour measurement excluded some patients, including those who died early, and the direction and extent of selection bias are indeterminate.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • The study assessed 30-day survival and good neurological outcome, defined as CPC 1 or 2.
      • The authors state that further studies with serial evaluations of renal function and kidney injury are required to clarify the physiological determinants and potential clinical value of this dynamic measurement.

      Risks

        Patient & Prescribing Data

        The analytic cohort comprised 375 patients with out-of-hospital cardiac arrest treated at 41 tertiary emergency hospitals in metropolitan Japan from September 2019 to March 2021; 209 survived and 166 did not.

        This observational study did not test a uric-acid-directed treatment. Temperature control was used in 55% of patients, with institutional targets of 34 °C, 35 °C, or 36 °C.

        Clinical Best Practices

        • The study found no significant survivor–non-survivor difference in admission serum uric acid, while a greater 24-hour decline was associated with outcomes.
        • The authors report an observational association and state that it was not shown to be independent of renal dysfunction.
        • The authors state that uric acid decline does not directly quantify renal uric acid clearance.
        • The authors identify exclusion of patients without 24-hour measurements, including some who died early, as a potential source of selection bias; its direction and extent are indeterminate.

        Related Resources & Content

          Original Source(s)

          Related Content